Walleye Trading
XENE icon

Walleye Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Walleye Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,923
Closed -$236K – 5557
2023
Q3 		$236K Buy
6,923
+1,254
+22% +$46.9K ﹤0.01% 3493
2023
Q2 		$218K Sell
5,669
-2,342
-29% -$93.1K ﹤0.01% 3371
2023
Q1 		$287K Buy
+8,011
New +$296K ﹤0.01% 3251
2022
Q4 		– Sell
-5,603
Closed -$202K – 5476
2022
Q3 		$202K Buy
+5,603
New +$201K ﹤0.01% 3663
2018
Q4 		– Sell
-11,470
Closed -$151K – 5403
2018
Q3 		$151K Buy
+11,470
New +$133K ﹤0.01% 3952
2016
Q2 		– Sell
-300
Closed -$2K – 5774
2016
Q1 		$2K Buy
+300
New +$2.16K ﹤0.01% 5130

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Trading's XENE Position: Q4 2023 in Review

Walleye Trading sold out of Xenon Pharmaceuticals (XENE) in Q4 2023, closing a stake of 6,923 shares — an estimated $236K sold.

Walleye Trading first reported a position in XENE in Q1 2016 and held it in 6 quarters. The position peaked at $287K in Q1 2023. 204 funds tracked by Wall St. Rank hold XENE as of Q4 2023.

  • Walleye Trading reported no remaining Xenon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 6,923 Xenon Pharmaceuticals shares in Q4 2023, an estimated $236K.
  • Walleye Trading first reported a position in Xenon Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Walleye Trading's Xenon Pharmaceuticals position peaked at $287K in Q1 2023.
  • 204 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.